Drug Database
Back to search

Belgium· BE-AMP-SAM662711-00

Awiqli 700 U/ml

A insulin icodec product containing insulin icodec, registered in Belgium by Novo Nordisk. The same ATC class is registered in 9 of our 19 countries.

ATC A10AE07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAwiqli 700 U/mlATCA10AE07REGISTER NO.BE-AMP-SAM662711-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insulin icodecAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin icodec is registered in 9 of 19 countries.

Countries holding a registration under ATC A10AE07 (insulin icodec), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search insulin icodec products by name

Insulin icodec · ATC A10AE07

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Insulin Icodec
Manufacturer
Novo Nordisk
Country
Belgium (BE)
ATC code
A10AE07
ATC class
Insulin icodec
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Insulin icodec in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All insulin icodec products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Awiqli
  • Norway · Awiqli

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1668b433-0c8e-49da-9fbd-ccf5e5bc73f4
GET /v1/drugs/1668b433-0c8e-49da-9fbd-ccf5e5bc73f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled pen",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Awiqli 700 U/ml",
  "name_fr": "Awiqli 700 U/ml",
  "name_nl": "Awiqli 700 U/ml",
  "amp_code": "SAM662711-00",
  "strengths": [
    "700.0000",
    "700.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Insulin Icodec"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Insulin Icodec",
  "authorisation_numbers": [
    "EU/1/24/1815/004",
    "EU/1/24/1815/006",
    "EU/1/24/1815/008",
    "EU/1/24/1815/005",
    "EU/1/24/1815/007"
  ]
}
API referenceMCP serverPlans

See everything about insulin icodec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console